Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis

Shitong Lin; Ting Peng; Yifan Meng; Canhui Cao; Peipei Gao; Ping Wu; Wenhua Zhi; Ye Wei; Tian Chu; Binghan Liu; Juncheng Wei; Xiaoyuan Huang; Wencheng Ding; Cai Cheng

doi:doi:10.18632/aging.203919

← Back

Research Paper Volume 14, Issue 4 pp 1959—1982

Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis

Figure 6. The forest plot of OR for ORR, CRR, and PRR in the weekly paclitaxel compared to 3-weeks paclitaxel regimen, respectively. OR: odds ratio; ORR: overall response rate; CRR: complete response rate; PRR: partial response rate.